The state chairman of IPMAN, Mr Ubong Isong who spoke to our correspondent in Uyo the state capital, said the association is doing everything possible to ensure
availability of the product in the state but lamented that major oil marketers in the state are frustrating the dealers with high cost procurement.
Collaboration can bring efficiencies and help communicate aggregated demand for products that can help drive
availability of these products in the market.
This is supposed to protect the book as a cultural asset, and ensure
availability of the product in a wide variety of sales channels.
Purchasing products from NASC members is the best way consumers can support efforts to improve the quality of animal health supplements and ensure the continued
availability of these products in the US market.
The availability of this product in terms of age and coverage amounts are the reasons why Great Western is considered one of the best guaranteed issue products for 2018.
Maximized
availability of products in appropriate channels of distribution consistent with brand strategy with an emphasis on superior new product execution.
• Improve work flow and turnover 10 % by actively implementing effective inventory control and management • Ensure
availability of products in the appropriate region timely, enhancing supply efficiency almost by double • Communicate effectively with management, stake holders and vendors regarding supply chain management and related issues • Control inventory levels to achieve concept sales and turnover targets • Develop appropriate distribution strategies and communicate assortment plan to distributing party • Determine purchase quantity based on OTB and rolling forecast
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases
in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect
of changes
in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and
availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or impact
of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential
product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations
in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Such risks, uncertainties and other factors include, without limitation: (1) the effect
of economic conditions
in the industries and markets
in which United Technologies and Rockwell Collins operate
in the U.S. and globally and any changes therein, including financial market conditions, fluctuations
in commodity prices, interest rates and foreign currency exchange rates, levels
of end market demand
in construction and
in both the commercial and defense segments
of the aerospace industry, levels
of air travel, financial condition
of commercial airlines, the impact
of weather conditions and natural disasters and the financial condition
of our customers and suppliers; (2) challenges
in the development, production, delivery, support, performance and realization
of the anticipated benefits
of advanced technologies and new
products and services; (3) the scope, nature, impact or timing
of acquisition and divestiture or restructuring activity, including the pending acquisition
of Rockwell Collins, including among other things integration
of acquired businesses into United Technologies» existing businesses and realization
of synergies and opportunities for growth and innovation; (4) future timing and levels
of indebtedness, including indebtedness expected to be incurred by United Technologies
in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including
in connection with the pending Rockwell Collins acquisition; (5) future
availability of credit and factors that may affect such
availability, including credit market conditions and our capital structure; (6) the timing and scope
of future repurchases
of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level
of other investing activities and uses
of cash, including
in connection with the proposed acquisition
of Rockwell; (7) delays and disruption
in delivery
of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits
of organizational changes; (11) the anticipated benefits
of diversification and balance
of operations across
product lines, regions and industries; (12) the outcome
of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact
of the negotiation
of collective bargaining agreements and labor disputes; (15) the effect
of changes
in political conditions
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate, including the effect
of changes
in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates
in the near term and beyond; (16) the effect
of changes
in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act
of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate; (17) the ability
of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result
in the imposition
of conditions that could adversely affect the combined company or the expected benefits
of the merger) and to satisfy the other conditions to the closing
of the pending acquisition on a timely basis or at all; (18) the occurrence
of events that may give rise to a right
of one or both
of United Technologies or Rockwell Collins to terminate the merger agreement, including
in circumstances that might require Rockwell Collins to pay a termination fee
of $ 695 million to United Technologies or $ 50 million
of expense reimbursement; (19) negative effects
of the announcement or the completion
of the merger on the market price
of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted
in their operation
of their businesses while the merger agreement is
in effect; (21) risks relating to the value
of the United Technologies» shares to be issued
in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability
of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
The biggest one to date for a biosimilar
product in the U.S. — the treatments have only been around for a handful
of years
in America despite widespread and long - standing
availability in Europe and other regions — Renflexis may ultimately not do much to curb health care and patient spending, as the Wall Street Journal «s Charley Grant points out
in an astute note.
Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations
of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost
of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations
in those rates; (5) the timing and market acceptance
of new
product offerings; (6) the
availability and cost
of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact
of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation
of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur
in the legal and regulatory proceedings described
in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).
«The launch
of Kenmore
products on Amazon.com will significantly expand the distribution and
availability of the Kenmore brand
in the U.S.,» Sears Holdings CEO Eddie Lampert said
in a statement.
Both offering mobile banking and effectively communicating the
availability of that
product to customers will be a defining factor
in which credit unions and banks succeed and which ones fail.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new
products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount
of discount required on Gilead's
products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration;
availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new
product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current
products, including Biktarvy; Gilead's ability to successfully commercialize its
products, including Biktarvy; the risk that physicians and patients may not see advantages
of these
products over other therapies and may therefore be reluctant to prescribe the
products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's
product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
These risks include,
in no particular order, the following: the trends toward more high - definition, on - demand and anytime, anywhere video will not continue to develop at its current pace or will expire; the possibility that our
products will not generate sales that are commensurate with our expectations or that our cost
of revenue or operating expenses may exceed our expectations; the mix
of products and services sold
in various geographies and the effect it has on gross margins; delays or decreases
in capital spending
in the cable, satellite, telco, broadcast and media industries; customer concentration and consolidation; the impact
of general economic conditions on our sales and operations; our ability to develop new and enhanced
products in a timely manner and market acceptance
of our new or existing
products; losses
of one or more key customers; risks associated with our international operations; exchange rate fluctuations
of the currencies
in which we conduct business; risks associated with our CableOS ™ and VOS ™
product solutions; dependence on market acceptance
of various types
of broadband services, on the adoption
of new broadband technologies and on broadband industry trends; inventory management; the lack
of timely
availability of parts or raw materials necessary to produce our
products; the impact
of increases
in the prices
of raw materials and oil; the effect
of competition, on both revenue and gross margins; difficulties associated with rapid technological changes
in our markets; risks associated with unpredictable sales cycles; our dependence on contract manufacturers and sole or limited source suppliers; and the effect on our business
of natural disasters.
Another benefit
of an annuity - not available
in non-insurance
products - is the
availability of a long - term care rider.
YOU FURTHER AGREE THAT THE
PRODUCTS AND OTHER MATERIALS YOU RECEIVE
IN YOUR ORDER MAY VARY FROM THE
PRODUCTS AND MATERIALS DISPLAYED ON THE SITES DUE TO A NUMBER
OF FACTORS, INCLUDING, WITHOUT LIMITATION, SYSTEM CAPABILITIES AND CONSTRAINTS
OF YOUR COMPUTER, MANUFACTURING PROCESS OR SUPPLY ISSUES, THE
AVAILABILITY AND VARIABILITY
OF PRODUCTS, DISTINCT COOKING OR OTHER PREPARATION METHODS AND VARIABILITY
OF COOKING EQUIPMENT AND APPLIANCES.
Factors that could cause actual results to differ include general business and economic conditions and the state
of the solar industry; governmental support for the deployment
of solar power; future available supplies
of high - purity silicon; demand for end - use
products by consumers and inventory levels
of such
products in the supply chain; changes
in demand from significant customers; changes
in demand from major markets such as Japan, the U.S., India and China; changes
in customer order patterns; changes
in product mix; capacity utilization; level
of competition; pricing pressure and declines
in average selling prices; delays
in new
product introduction; delays
in utility - scale project approval process; delays
in utility - scale project construction; delays
in the completion
of project sales; continued success
in technological innovations and delivery
of products with the features customers demand; shortage
in supply
of materials or capacity requirements;
availability of financing; exchange rate fluctuations; litigation and other risks as described
in the Company's SEC filings, including its annual report on Form 20 - F filed on April 27, 2017.
Factors that could cause actual results to differ include general business and economic conditions and the state
of the solar industry; governmental support for the deployment
of solar power; future available supplies
of high - purity silicon; demand for end - use
products by consumers and inventory levels
of such
products in the supply chain; changes
in demand from significant customers; changes
in demand from major markets such as Japan, the U.S., India and China; changes
in customer order patterns; changes
in product mix; capacity utilization; level
of competition; pricing pressure and declines
in average selling prices; delays
in new
product introduction; delays
in utility - scale project approval process; delays
in utility - scale project construction; continued success
in technological innovations and delivery
of products with the features customers demand; shortage
in supply
of materials or capacity requirements;
availability of financing; exchange rate fluctuations; litigation and other risks as described
in the Company's SEC filings, including its annual report on Form 20 - F filed on April 20, 2016.
Factors that could cause actual results to differ include general business and economic conditions and the state
of the solar industry; governmental support for the deployment
of solar power; future available supplies
of high - purity silicon; demand for end - use
products by consumers and inventory levels
of such
products in the supply chain; changes
in demand from significant customers; changes
in demand from major markets such as Japan, the U.S., India and China; changes
in customer order patterns; changes
in product mix; capacity utilization; level
of competition; pricing pressure and declines
in average selling prices; delays
in new
product introduction; delays
in utility - scale project approval process; delays
in utility - scale project construction; cancelation
of utility - scale feed -
in - tariff contracts
in Japan; continued success
in technological innovations and delivery
of products with the features customers demand; shortage
in supply
of materials or capacity requirements;
availability of financing; exchange rate fluctuations; litigation and other risks as described
in the Company's SEC filings, including its annual report on Form 20 - F filed on April 27, 2017.
Please consult your own professional adviser for further information on
availability of products and services
in your jurisdiction.
We caution you that these statements are not guarantees
of future performance and are subject to numerous risks and uncertainties, including volatility
in the economy and the credit markets, supply and demand changes for vacation ownership and residential
products, competitive conditions; the
availability of capital to finance growth, and other matters referred to under the heading «Risk Factors» contained
in our Annual Report on 10 - K for the year ended December 30, 2011 filed with the U.S. Securities and Exchange Commission (the «SEC») and
in subsequent SEC filings, any
of which could cause actual results to differ materially from those expressed
in or implied
in this presentation.
U.S. Bank is not responsible for the content
of, or
products and services provided by FINRA, nor does it guarantee the system
availability or accuracy
of information contained
in the site.
Factors that could cause actual results to differ materially from those expressed or implied
in any forward - looking statements include, but are not limited to: changes
in consumer discretionary spending; our eCommerce platform not producing the anticipated benefits within the expected time - frame or at all; the streamlining
of the Company's vendor base and execution
of the Company's new merchandising strategy not producing the anticipated benefits within the expected time - frame or at all; the amount that we invest
in strategic transactions and the timing and success
of those investments; the integration
of strategic acquisitions being more difficult, time - consuming, or costly than expected; inventory turn; changes
in the competitive market and competition amongst retailers; changes
in consumer demand or shopping patterns and our ability to identify new trends and have the right trending
products in our stores and on our website; changes
in existing tax, labor and other laws and regulations, including those changing tax rates and imposing new taxes and surcharges; limitations on the
availability of attractive retail store sites; omni - channel growth; unauthorized disclosure
of sensitive or confidential customer information; risks relating to our private brand offerings and new retail concepts; disruptions with our eCommerce platform, including issues caused by high volumes
of users or transactions, or our information systems; factors affecting our vendors, including supply chain and currency risks; talent needs and the loss
of Edward W. Stack, our Chairman and Chief Executive Officer; developments with sports leagues, professional athletes or sports superstars; weather - related disruptions and seasonality
of our business; and risks associated with being a controlled company.
The
availability of a streamlined version
of the exemption for level - fee advisors makes selling fee - based
products more attractive for advisory firms, which can be held liable for advisors who, as DOL fiduciaries, sell
products that are not
in the client's best interests.
These risks and uncertainties include food safety and food - borne illness concerns; litigation; unfavorable publicity; federal, state and local regulation
of our business including health care reform, labor and insurance costs; technology failures; failure to execute a business continuity plan following a disaster; health concerns including virus outbreaks; the intensely competitive nature
of the restaurant industry; factors impacting our ability to drive sales growth; the impact
of indebtedness we incurred
in the RARE acquisition; our plans to expand our newer brands like Bahama Breeze and Seasons 52; our ability to successfully integrate Eddie V's restaurant operations; a lack
of suitable new restaurant locations; higher - than - anticipated costs to open, close or remodel restaurants; increased advertising and marketing costs; a failure to develop and recruit effective leaders; the price and
availability of key food
products and utilities; shortages or interruptions
in the delivery
of food and other
products; volatility
in the market value
of derivatives; general macroeconomic factors, including unemployment and interest rates; disruptions
in the financial markets; risk
of doing business with franchisees and vendors
in foreign markets; failure to protect our service marks or other intellectual property; a possible impairment
in the carrying value
of our goodwill or other intangible assets; a failure
of our internal controls over financial reporting or changes
in accounting standards; and other factors and uncertainties discussed from time to time
in reports filed by Darden with the Securities and Exchange Commission.
These risks and uncertainties include: fluctuations
in U.S. and international economies and currencies, our ability to preserve, grow and leverage our brands, potential negative effects
of material breaches
of our information technology systems if any were to occur, costs associated with, and the successful execution
of, the company's initiatives and plans, the acceptance
of the company's
products by our customers, the impact
of competition, coffee, dairy and other raw material prices and
availability, the effect
of legal proceedings, and other risks detailed
in the company filings with the Securities and Exchange Commission, including the «Risk Factors» section
of Starbucks Annual Report on Form 10 - K for the fiscal year ended September 28, 2014.
Greater
availability of data on potential borrowers and new techniques to analyse that data allowed lenders to design
products that were,
in principle, better tailored to that part
of the market.
One thing holding back household spending
in smaller cities is the lack
of physical retail infrastructure and
product availability,
in part due to the sheer geographic scope
of the market — while UBS determined China has four tier 1 cities (Beijing, Shanghai, Guangzhou and Shenzhen) there are nearly 200 tier 4 cities alone.
We caution you that these statements are not guarantees
of future performance and are subject to numerous risks and uncertainties, including volatility
in the economy and the credit markets, supply and demand changes for vacation ownership and residential
products, competitive conditions; the
availability of capital to finance growth, and other matters referred to under the heading «Risk Factors» contained
in the Information Statement filed as an exhibit to our Annual Report on Form 10 - K for the year ended December 30, 2011 filed with the U.S. Securities and Exchange Commission (the «SEC») and
in subsequent SEC filings, any
of which could cause actual results to differ materially from those expressed
in or implied
in this presentation.
You are encouraged to stay
in close contact with your DSG sales associate due to increased price volatility and fluid nature
of product availability.
Be sure to cash
in on this
availability of data, as it can elevate your prospect's overall perception
of your
products and will help them view you as a trusted resource.
The company cautions you that these statements are not guarantees
of future performance and are subject to numerous risks and uncertainties, including volatility
in the economy and the credit markets, supply and demand changes for vacation ownership and residential
products, competitive conditions; the
availability of capital to finance growth, and other matters referred to under the heading «Risk Factors» contained
in the company's most recent Annual Report on Form 10 - K filed with the U.S Securities and Exchange Commission (the «SEC») and
in subsequent SEC filings, any
of which could cause actual results to differ materially from those expressed
in or implied
in this press release.
They work with corporations to increase the
availability of animal
product alternatives and have developed a «restaurant report card» to score the top 100 chain restaurants according to their plant - based options.22
In general, we think that corporate outreach is a relatively effective animal advocacy intervention, though we are less certain of the effects of promoting plant - based options in restaurants than we are of the effects of working with corporations to implement welfare reform
In general, we think that corporate outreach is a relatively effective animal advocacy intervention, though we are less certain
of the effects
of promoting plant - based options
in restaurants than we are of the effects of working with corporations to implement welfare reform
in restaurants than we are
of the effects
of working with corporations to implement welfare reforms.
At the same time, we were affected by the limited
availability of innovative new
products in the market.»
The widespread promotion
of the
products of western capitalism, coupled with increased
availability of goods and the sustained cultivation
of desire through commercial media, has led to a profound influence
of the philosophy
of consumerism
in western societies and increasingly
in developing countries as well.
The company also announced new retail partnerships with grocery giants, Jewel, Wegmans and Kroger
in addition to its current relationships with select Whole Foods, Mariano's, and other smaller retailers — expanding
in - store
availability four fold and doubling the number
of U.S. states where the
product is currently sold.
The company also publishes a weekly newsletter to inform its customers on the
availability of certain
products and trends
in their preparation.
New
product development
in the pizza category has a sharp focus on authentic, restaurant - quality
products suitable to share with family and friends and available for impulse or advance purchase.2 The wide retail
availability of ready - to - bake frozen and chilled fresh pizzas provides consumers with a convenient and cost - effective alternative to home delivery, take - away and eat -
in restaurants.2
Farmers market where regional producers come together to sell their goods locally resulting
in the
availability of the highest quality produce and
products.
Colbert Packaging Corporation, a manufacturer
of folding cartons, rigid paper boxes and paperboard specialty
products, today announced the
availability of MedLock EZ, its latest invention
in patient compliance packaging solutions.
Due to the easy
availability of corn, sorghum, and quinoa,
product innovations for bakery
products have been based on these gluten - free sources
in the developed markets
of the U.S., Canada, Italy, and Germany.
In addition to leading the way for other brands to begin removing toxins from their products, this shift could likely impact the global supply market in upcoming years, increasing the availability (and decreasing the cost) of higher quality plant - based ingredients or safer chemicals that could be used in personal care products across market
In addition to leading the way for other brands to begin removing toxins from their
products, this shift could likely impact the global supply market
in upcoming years, increasing the availability (and decreasing the cost) of higher quality plant - based ingredients or safer chemicals that could be used in personal care products across market
in upcoming years, increasing the
availability (and decreasing the cost)
of higher quality plant - based ingredients or safer chemicals that could be used
in personal care products across market
in personal care
products across markets.
However, wider challenges remain for the sector, not just
in terms
of rising raw material prices, but also
in managing the volatility
in the price and supply
of many key commodities, and ensuring the continuity
of supply when
product availability is short
in the UK or globally.»
While the
availability of whey and lactose
products continue to climb during 2008, price volatility has managed to hamper hikes
in profitability
of the segment as manufacturers hunt for cheaper ingredients, says a new report.
The National Restaurant Association's 2014 Forecast indicates that for six
in 10 frequent fast - food diners — one
of the representative demographics purchasing the most battered and breaded food
products — the
availability of healthier menu items rank high as a decision - making factor for choosing fast food.
Since I am
in Mexico my
availability of specialty
products is sort
of limited.
At present, there is limited
availability of gluten - free craft beers
in the licensed on - trade and Bellfield Brewery hopes to address that while also supplying independent specialists and multiple retailers with
products that consumers can enjoy at home.
Household
availability of ready - to - consume food and drink
products in Chile: impact on nutritional quality
of the diet
Easier
availability of frozen foods has influenced the purchasing patterns
of consumer regarding dietary
products, rendering a firm place for frozen foods
in their list
of daily consumables.